How robust is ACTIVLIM for the follow-up of activity limitations in patients with neuromuscular diseases?

MLA

Batcho, Charles Sèbiyo, et al. “How Robust Is ACTIVLIM for the Follow-up of Activity Limitations in Patients with Neuromuscular Diseases?” Neuromuscular Disorders : NMD, vol. 26, no. 3, Mar. 2016, pp. 211–20. EBSCOhost, https://doi.org/10.1016/j.nmd.2015.12.004.

APA

Batcho, C. S., Van den Bergh, P. Y. K., Van Damme, P., Roy, A. J., Thonnard, J.-L., & Penta, M. (2016). How robust is ACTIVLIM for the follow-up of activity limitations in patients with neuromuscular diseases? Neuromuscular Disorders : NMD, 26(3), 211–220. https://doi.org/10.1016/j.nmd.2015.12.004

Chicago

Batcho, Charles Sèbiyo, Peter Y K Van den Bergh, Philip Van Damme, Anna J Roy, Jean-Louis Thonnard, and Massimo Penta. 2016. “How Robust Is ACTIVLIM for the Follow-up of Activity Limitations in Patients with Neuromuscular Diseases?” Neuromuscular Disorders : NMD 26 (3): 211–20. doi:10.1016/j.nmd.2015.12.004.